UY33411A - USE OF TERIFLUNOMIDE FOR THE TREATMENT OF BRAIN ATROPHY - Google Patents

USE OF TERIFLUNOMIDE FOR THE TREATMENT OF BRAIN ATROPHY

Info

Publication number
UY33411A
UY33411A UY0001033411A UY33411A UY33411A UY 33411 A UY33411 A UY 33411A UY 0001033411 A UY0001033411 A UY 0001033411A UY 33411 A UY33411 A UY 33411A UY 33411 A UY33411 A UY 33411A
Authority
UY
Uruguay
Prior art keywords
teriflunomide
treatment
brain atrophy
atrophy
brain
Prior art date
Application number
UY0001033411A
Other languages
Spanish (es)
Inventor
Byrnes William
Original Assignee
Sanofi Aventis Us Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Us Llc filed Critical Sanofi Aventis Us Llc
Publication of UY33411A publication Critical patent/UY33411A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere al uso de reriflunomida para tratar la atrofia cerebral en un paciente que lo necesita.The present invention relates to the use of reriflunomide to treat cerebral atrophy in a patient in need.

UY0001033411A 2010-05-26 2011-05-26 USE OF TERIFLUNOMIDE FOR THE TREATMENT OF BRAIN ATROPHY UY33411A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34849410P 2010-05-26 2010-05-26
US38937510P 2010-10-04 2010-10-04
US39140010P 2010-10-08 2010-10-08

Publications (1)

Publication Number Publication Date
UY33411A true UY33411A (en) 2011-12-30

Family

ID=44211940

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033411A UY33411A (en) 2010-05-26 2011-05-26 USE OF TERIFLUNOMIDE FOR THE TREATMENT OF BRAIN ATROPHY

Country Status (4)

Country Link
AR (1) AR081220A1 (en)
TW (1) TW201208674A (en)
UY (1) UY33411A (en)
WO (1) WO2011150014A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012061062A1 (en) * 2010-10-25 2012-05-10 Sanofi-Aventis U.S. Llc Use of teriflunomide for improving motor function

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268382A (en) 1985-09-27 1993-12-07 Hoechst Aktiengesellschaft Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
GB0123571D0 (en) 2001-04-05 2001-11-21 Aventis Pharm Prod Inc Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis

Also Published As

Publication number Publication date
AR081220A1 (en) 2012-07-04
TW201208674A (en) 2012-03-01
WO2011150014A1 (en) 2011-12-01

Similar Documents

Publication Publication Date Title
ECSP14017269A (en) COMPOUNDS TO TREAT SPINAL MUSCULAR ATROPHY
CU20120161A7 (en) 5-FLUORO-1H-SUBSTITUTED PIRAZOLOPIRIDINS
CR20140410A (en) ESKETAMINE FOR THE TREATMENT OF DEPRESSION REFRACTORY TO TREATMENT OR TREATMENT RESISTANT
CO6771447A2 (en) Cyclopropylamines as lysine specific demethylase 1 inhibitors
GT201200016A (en) DERIVATIVES OF OXAZINE AND ITS USE AS BACE INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
UY34165A (en) ? ALDH-2 HUMAN MITOCONDRIAL COMPOUNDS FOR ADDICTION TREATMENT ?.
CR20130464A (en) ACETIL-COA CARBOXILASA REPLACED INHIBITORS
MX356728B (en) Pharmaceutical combination for use in the treatment of diabetes type 2.
BR112013022234A2 (en) dodecafluorpentane emulsion as a stroke and ischemia therapy
CO7160080A2 (en) Lipid compositions of racecadot
UY35276A (en) New compounds that inhibit the activity of Lp-PLA2
GT201400242A (en) "NEW COMPOUNDS OF PIRAZOL"
BR112014019399A2 (en) fibrosis treatment methods
ES2569743R1 (en) Use of buprenorphine in the manufacture of a medication to treat opioid-induced side effects
EP2797593A4 (en) Silicone-based composition for skin treatment
FI20115165A0 (en) Therapeutic and diagnostic methods
CO7121334A2 (en) Vesicular formulations
BR112014017587A2 (en) Methods and Formulations for the Treatment of Sialic Acid Deficiencies
BR112014009760A8 (en) sialic acid analogs
BR112014000670A2 (en) use of oligosaccharide compounds for the prevention and treatment of pathological scars
SV2011003784A (en) NIFURTIMOX FOR THE TREATMENT OF DISEASES CAUSED BY TRICHOMONADIDA
UY33411A (en) USE OF TERIFLUNOMIDE FOR THE TREATMENT OF BRAIN ATROPHY
ECSP17021138A (en) DIPEPTIDIL-KETOAMIDE COMPOUNDS AND THEIR USE FOR THE TREATMENT AND / OR PREVENTION OF FAT ACCUMULATION
UY33542A (en) USE OF TERIFLUNOMIDE TO TREAT MULTIPLE SCLEROSIS

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20200629